FRET

By Ben Butkus
Biosearch Technologies said today that it has acquired worldwide rights from the University of Medicine and Dentistry of New Jersey to patents covering "non-FRET" nucleic acid probe technology.

The new test will be based on real-time PCR using fluorescence resonance energy transfer probes for detection.

The scientist has founded consulting firm Perpetual Genomics to license the technology, which would be a "true universal library" of extremely short FRET-based PCR probes that could allow manufacturers to sell probes fractionally and significantly reduce their cost.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.